Mark Giganti, PhD

Research Scientist
Harvard T.H. Chan School of Public Health
Boston, MA, United States

Dr. Mark Giganti is a research scientist at the Center for Biostatistics AIDS Research and Harvard T.H. Chan School of Public Health. He received his PhD in Biostatistics from Vanderbilt University and currently works as a senior statistician on multiple infectious disease clinical trials related to RSV, HIV, and COVID-19 as part of the ACTG and IMPAACT networks.

I do not have any relevant financial / non-financial relationships with any proprietary interests.

Presentation(s):

• 878 - Association between Anterior Nasal and Plasma SARS-CoV-2 RNA Levels and Hospitalization or Death for Non-Hospitalized Adults with Mild-to-Moderate COVID-19

  Friday, October 21, 2022
  10:30 AM – 10:45 AM US ET

• 881 - Nasal and Plasma SARS-CoV-2 RNA Levels Predict Timing of Symptom Resolution in the ACTIV-2 Trial of Non-hospitalized Adults with COVID-19

  Friday, October 21, 2022
  11:15 AM – 11:30 AM US ET